David Domzalski - Sep 30, 2022 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
President and CEO, Director
Signature
/s/ Mutya Harsch, attorney-in-fact for David Domzalski
Stock symbol
VYNE
Transactions as of
Sep 30, 2022
Transactions value $
-$2,382
Form type
4
Date filed
10/4/2022, 05:00 PM
Previous filing
Jul 5, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$2.38K -10.7K -1.02% $0.22 1.04M Sep 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.